Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Tuberculosis

  Free Subscription


Articles published in J Infect Dis

Retrieve available abstracts of 68 articles:
HTML format
Text format



Single Articles


    February 2017
  1. HALLIDAY A, Whitworth H, Hermagild Kottoor S, Niazi U, et al
    Stratification of latent tuberculosis infection by cellular immune profiling.
    J Infect Dis. 2017 Feb 28. doi: 10.1093.
    PubMed     Text format     Abstract available


    January 2017
  2. CLARK S, Lanni F, Marinova D, Rayner E, et al
    Revaccination of Guinea Pigs With the Live Attenuated Mycobacterium tuberculosis Vaccine MTBVAC Improves BCG's Protection Against Tuberculosis.
    J Infect Dis. 2017 Jan 25. doi: 10.1093.
    PubMed     Text format     Abstract available


    December 2016
  3. MARAIS S, Lai RP, Wilkinson KA, Meintjes G, et al
    Inflammasome activation underlies central nervous system deterioration in HIV-associated tuberculosis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    October 2016
  4. JEYANATHAN M, Damjanovic D, Yao Y, Bramson J, et al
    Induction of an immune protective T cell repertoire with diverse genetic coverage by a novel viral-vectored tuberculosis vaccine in man.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    September 2016
  5. MARTINEZ N, Ketheesan N, West K, Vallerskog T, et al
    Impaired Recognition of Mycobacterium tuberculosis by Alveolar Macrophages from Diabetic Mice.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    August 2016
  6. SCHLUGER NW
    Host-pathogen interactions in tuberculosis: the evolving story.
    J Infect Dis. 2016.
    PubMed     Text format    


  7. WALTER ND, de Jong BC, Garcia BJ, Dolganov GM, et al
    Adaptation of M. tuberculosis to impaired host immunity in HIV-infected patients.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  8. CHEN L, Zhang J, Zhang H
    Heteroresistance of Mycobacterium tuberculosis strains may be associated more strongly with poor treatment outcomes than within-host heterogeneity of M. tuberculosis infection.
    J Infect Dis. 2016.
    PubMed     Text format    


  9. HORNE DJ, Graustein AD, Shah JA, Peterson G, et al
    Human ULK1 Variation and Susceptibility to Mycobacterium tuberculosis Infection.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  10. DINARDO AR, Mace EM, Lesteberg K, Cirillo JD, et al
    Schistosome Soluble Egg Antigen Decreases Mycobacterium tuberculosis-Specific CD4+ T-Cell Effector Function With Concomitant Arrest of Macrophage Phago-Lysosome Maturation.
    J Infect Dis. 2016;214:479-88.
    PubMed     Text format     Abstract available


  11. AHSAN F, Moura-Alves P, Guhlich-Bornhof U, Klemm M, et al
    Role of Interleukin 36gamma in Host Defense Against Tuberculosis.
    J Infect Dis. 2016;214:464-74.
    PubMed     Text format     Abstract available


    July 2016
  12. DIEDRICH CR, O'Hern J, Gutierrez MG, Allie N, et al
    Relationship between HIV-1 co-infection, IL-10, and M. tuberculosis in human lymph node granulomas.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  13. YANG HJ, Kong Y, Cheng Y, Janagama H, et al
    Real-Time Imaging of Mycobacterium tuberculosis Using a Novel Near-Infrared Fluorescent Substrate.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    May 2016
  14. SCRIBA TJ, Kaufmann SH, Lambert PH, Sanicas M, et al
    Vaccination against tuberculosis with whole cell mycobacterial vaccines.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  15. SHEPELKOVA G, Evstifeev V, Majorov K, Bocharova I, et al
    Therapeutic effect of recombinant mutated IL-11 in the mouse model of tuberculosis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    April 2016
  16. PRADOS-ROSALES R, Carreno LJ, Weinrick B, Batista-Gonzalez A, et al
    The Type of Growth Medium Affects the Presence of a Mycobacterial Capsule and Is Associated With Differences in Protective Efficacy of BCG Vaccination Against Mycobacterium tuberculosis.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


  17. JOLOBA M, Mwangi C, Alexander H, Nadunga D, et al
    Strengthening the Tuberculosis Specimen Referral Network in Uganda: The Role of Public-Private Partnerships.
    J Infect Dis. 2016;213 Suppl 2:S41-6.
    PubMed     Text format     Abstract available


  18. JABOT-HANIN F, Cobat A, Feinberg J, Grange G, et al
    Major Loci on Chromosomes 8q and 3q Control Interferon gamma Production Triggered by Bacillus Calmette-Guerin and 6-kDa Early Secretory Antigen Target, Respectively, in Various Populations.
    J Infect Dis. 2016;213:1173-9.
    PubMed     Text format     Abstract available


    March 2016
  19. MINHINNICK A, Harris S, Wilkie M, Peter J, et al
    Optimization of a Human Bacille Calmette-Guerin Challenge Model: A Tool to Evaluate Antimycobacterial Immunity.
    J Infect Dis. 2016;213:824-30.
    PubMed     Text format     Abstract available


    January 2016
  20. COHEN T, Chindelevitch L, Misra R, Kempner ME, et al
    Within-host heterogeneity of M. tuberculosis infection is associated with poor early treatment response: a prospective cohort study.
    J Infect Dis. 2016.
    PubMed     Text format     Abstract available


    November 2015
  21. BOILLAT-BLANCO N, Ramaiya KL, Mganga M, Minja LT, et al
    Transient Hyperglycemia in Patients with Tuberculosis in Tanzania: Implications for Diabetes Screening Algorithms.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  22. ELLIOTT TO, Owolabi O, Donkor S, Kampmann B, et al
    Dysregulation of Apoptosis Is a Risk Factor for Tuberculosis Disease Progression.
    J Infect Dis. 2015;212:1469-79.
    PubMed     Text format     Abstract available


    October 2015
  23. AGUILO N, Alvarez-Arguedas S, Uranga S, Marinova D, et al
    Pulmonary but not subcutaneous vaccination confers protection to TB susceptible mice by an IL17-dependent mechanism.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  24. KUMAR NP, Moideen K, George PJ, Dolla C, et al
    Impaired cytokine but enhanced cytotoxic marker expression in Mycobacterium tuberculosis - induced CD8+ T cells in Type 2 diabetic individuals with latent tuberculosis.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    September 2015
  25. KUBLER A, Larsson C, Luna B, Andrade BB, et al
    Cathepsin K Contributes to Cavitation and Collagen Turnover in Pulmonary Tuberculosis.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  26. KASPROWICZ VO, Cheng TY, Ndung'u T, Sunpath H, et al
    HIV disrupts human T cells that target mycobacterial glycolipids.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  27. CLIFF JM, Cho JE, Lee JS, Ronacher K, et al
    Excessive Cytolytic Responses Predict Tuberculosis Relapse After Apparently Successful Treatment.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    July 2015
  28. ZELNER JL, Murray MB, Becerra MC, Galea J, et al
    Identifying hotspots of multidrug resistant tuberculosis transmission using spatial and molecular genetic data.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  29. ARMITAGE AE, Moran E
    HIV-associated tuberculosis: does the iron-regulatory hormone hepcidin connect anemia with poor prognosis?
    J Infect Dis. 2015.
    PubMed     Text format    


  30. KERKHOFF AD, Meintjes G, Burton R, Vogt M, et al
    Relationship between blood concentrations of hepcidin and anaemia severity, mycobacterial burden and mortality in patients with HIV-associated tuberculosis.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  31. PASIPANODYA J, Srivastava S, Gumbo T
    Fatal Lure of Look-Back Studies in Explaining Pharmacological Events Such as Acquired Drug Resistance in Patients With Multidrug-Resistant Tuberculosis.
    J Infect Dis. 2015;212:166-7.
    PubMed     Text format    


    June 2015
  32. SALVATORE PP, Becerra MC, Zur Wiesch PA, Hinkley T, et al
    Fitness Costs of Drug-resistance Mutations in Multidrug Resistant M. tuberculosis: A Household-based Case-control Study.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  33. NUERMBERGER E, Hanna D
    Assessing the landscape of tools and approaches for novel tuberculosis regimen development.
    J Infect Dis. 2015;211 Suppl 3:S81-2.
    PubMed     Text format    


  34. MCILLERON H, Abdel-Rahman S, Dave JA, Blockman M, et al
    Special populations and pharmacogenetic issues in tuberculosis drug development and clinical research.
    J Infect Dis. 2015;211 Suppl 3:S115-25.
    PubMed     Text format     Abstract available


  35. GUMBO T, Angulo-Barturen I, Ferrer-Bazaga S
    Pharmacokinetic-pharmacodynamic and dose-response relationships of antituberculosis drugs: recommendations and standards for industry and academia.
    J Infect Dis. 2015;211 Suppl 3:S96-S106.
    PubMed     Text format     Abstract available


  36. GUMBO T, Lenaerts AJ, Hanna D, Romero K, et al
    Nonclinical models for antituberculosis drug development: a landscape analysis.
    J Infect Dis. 2015;211 Suppl 3:S83-95.
    PubMed     Text format     Abstract available


  37. SAHASRABUDHE V, Zhu T, Vaz A, Tse S, et al
    Drug metabolism and drug interactions: potential application to antituberculosis drugs.
    J Infect Dis. 2015;211 Suppl 3:S107-14.
    PubMed     Text format     Abstract available


  38. AICHELBURG MC
    Reply to Schepisi et al.
    J Infect Dis. 2015;211:1854.
    PubMed     Text format    


    May 2015
  39. PAN SJ, Tapley A, Adamson J, Little T, et al
    Biomarkers for tuberculosis based on secreted, species-specific, bacterial small molecules.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    April 2015
  40. WEYER K
    Discovery, Innovation, and New Frontiers in Tuberculosis Diagnostics: Reflections and Expectations.
    J Infect Dis. 2015;211.
    PubMed     Text format    


  41. PANTOJA A, Kik SV, Denkinger CM
    Costs of Novel Tuberculosis Diagnostics-Will Countries Be Able to Afford It?
    J Infect Dis. 2015;211.
    PubMed     Text format     Abstract available


  42. KIK SV, Denkinger CM, Jefferson C, Ginnard J, et al
    Potential Market for Novel Tuberculosis Diagnostics: Worth the Investment?
    J Infect Dis. 2015;211.
    PubMed     Text format     Abstract available


  43. SALAMON H, Yamaguchi KD, Cirillo DM, Miotto P, et al
    Integration of Published Information Into a Resistance-Associated Mutation Database for Mycobacterium tuberculosis.
    J Infect Dis. 2015;211.
    PubMed     Text format     Abstract available


  44. DENKINGER CM, Kik SV, Cirillo DM, Casenghi M, et al
    Defining the Needs for Next Generation Assays for Tuberculosis.
    J Infect Dis. 2015;211.
    PubMed     Text format     Abstract available


  45. PAI M, Schito M
    Tuberculosis Diagnostics in 2015: Landscape, Priorities, Needs, and Prospects.
    J Infect Dis. 2015;211.
    PubMed     Text format     Abstract available


  46. DENKINGER CM, Dolinger D, Schito M, Wells W, et al
    Target product profile of a molecular drug-susceptibility test for use in microscopy centers.
    J Infect Dis. 2015;211 Suppl 2:S39-49.
    PubMed     Text format     Abstract available


    March 2015
  47. CRAWFORD CL
    The epithelioid cell in tuberculosis is secretory and not a macrophage.
    J Infect Dis. 2015.
    PubMed     Text format    


  48. STEPHEN-VICTOR E, Saha C, Sharma M, Holla S, et al
    Inhibition of programmed death 1 ligand 1 on dendritic cells enhances Mycobacterium-mediated interferon gamma (IFN-gamma) production without modulating the frequencies of IFN-gamma-producing CD4+ T cells.
    J Infect Dis. 2015;211:1027-9.
    PubMed     Text format    


  49. MITRA DK, Singh A, Mohan A, Dey AB, et al
    Reply to Stephen-Victor et al.
    J Infect Dis. 2015;211:1029-31.
    PubMed     Text format    


  50. KOLLMANN TR
    BCG modulates neonatal innate immune cytokine production.
    J Infect Dis. 2015;211:859-60.
    PubMed     Text format    


  51. WALTER ND, Dolganov GM, Garcia BJ, Worodria W, et al
    Transcriptional adaptation of drug-tolerant Mycobacterium tuberculosis during treatment of human tuberculosis.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  52. ARCOS J, Diangelo LE, Scordo JM, Sasindran SJ, et al
    Lung mucosa lining fluid modifies Mycobacterium tuberculosis to reprogram human neutrophil killing mechanisms.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    February 2015
  53. AL SHAMMARI B, Shiomi T, Tezera L, Bielecka MK, et al
    The extracellular matrix regulates granuloma necrosis in tuberculosis.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  54. CHODISETTI SB, Gowthaman U, Rai PK, Vidyarthi A, et al
    Triggering through Toll-like receptor 2 limits chronically stimulated T-helper type 1 cells from undergoing exhaustion.
    J Infect Dis. 2015;211:486-96.
    PubMed     Text format     Abstract available


    January 2015
  55. ORR MT, Plessner Windish H, Beebe EA, Argilla D, et al
    IFN-gamma and TNF are not essential parameters of CD4 T cell responses for vaccine control of tuberculosis.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  56. SANE SCHEPISI M, Parracino MP, Mammone A, Bellagamba R, et al
    Effect of immune status on serial QuantiFERON-TB Gold In-Tube LTBI screening in persons with HIV in a low TB incidence country.
    J Infect Dis. 2015.
    PubMed     Text format    


  57. COSCOLLA M, Barry PM, Oeltmann JE, Koshinsky H, et al
    Genomic Epidemiology of Multidrug-resistant Mycobacterium tuberculosis During Transcontinental Spread.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


  58. LEE RS, Radomski N, Proulx JF, Manry J, et al
    Re-emergence and Amplification of Tuberculosis in the Canadian Arctic.
    J Infect Dis. 2015.
    PubMed     Text format     Abstract available


    December 2014
  59. SAIGA H, Nieuwenhuizen N, Gengenbacher M, Koehler AB, et al
    The recombinant BCG DeltaureC::hly vaccine targets the AIM2 inflammasome to induce autophagy and inflammation.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


  60. FENG Y, Dorhoi A, Mollenkopf HJ, Yin H, et al
    Platelets direct monocyte differentiation into epithelioid-like multinucleated giant foam cells with suppressive capacity upon mycobacterial stimulation.
    J Infect Dis. 2014;210:1700-10.
    PubMed     Text format     Abstract available


    November 2014
  61. YATES TA, Abubakar I, Tanser F
    Re: Transmission of Tuberculosis in a South African Community With a High Prevalence of HIV Infection.
    J Infect Dis. 2014.
    PubMed     Text format    


  62. TURNER RD, Bothamley GH
    Cough and the transmission of tuberculosis.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


  63. MIDDELKOOP K, Mathema B, Whitelaw A, Bekker LG, et al
    Reply to Yates et al.
    J Infect Dis. 2014.
    PubMed     Text format    


    October 2014
  64. STUCKI D, Ballif M, Bodmer T, Coscolla M, et al
    Tracking a tuberculosis outbreak over 21 years: strain-specific single nucleotide polymorphism-typing combined with targeted whole genome sequencing.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


    September 2014
  65. JENSEN KJ, Larsen N, Biering-Sorensen S, Andersen A, et al
    Heterologous immunological effects of early BCG vaccination in low-birth weight infants in Guinea-Bissau: a randomized-controlled trial.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


    August 2014
  66. TOUKAM TCHAKOUTE C, Hesseling AC, Kidzeru EB, Gamieldien H, et al
    Delaying BCG vaccination until 8 weeks of age results in robust BCG-specific T cell responses in HIV-exposed infants.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


    July 2014
  67. BORGDORFF MW, Cain KP, De Cock KM
    The molecular epidemiology of TB in settings with high HIV prevalence: implications for control.
    J Infect Dis. 2014.
    PubMed     Text format    


  68. MIDDELKOOP K, Mathema B, Myer L, Shashkina E, et al
    Transmission of TB in a high HIV prevalent South African community.
    J Infect Dis. 2014.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Tuberculosis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: